Exagen Inc.
XGN- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001274737
In the last 90 days, Exagen Inc. insiders filed 0 open-market purchases and 1 sale; 57 institutions reported holding it in 13F filings for Q2 2026, worth $37.0M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Exagen Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 53 | 53 | 0 |
| Shares | 8.78M | 8.60M | −180.2K (−2.1%) |
| Value | $119.6M | $100.0M | −$19.6M (−16.4%) |
New holders (5)
Institutions that held Exagen Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Paradigm Capital Management Inc | 41,666 | $485.0K | 0.02% |
| Allspring Global Investments Holdings, LLC | 3,016 | $35.0K | 0.00% |
| Amplius Wealth Advisors, LLC | 497 | $5.00K | 0.00% |
| US Bancorp | 73 | $1.00K | 0.00% |
| Simplex Trading, LLC | 12 | $0 | 0.00% |
Sold out (5)
Institutions that held Exagen Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Samjo Capital LLC | 295,000 | $4.01M |
| EMC Capital Management | 32,447 | $377.0K |
| Russell Investments Group, Ltd. | 26,288 | $357.0K |
| Calamos Advisors LLC | 11,768 | $160.0K |
| American Portfolios Advisors | 1,063 | $14.5K |